Patient stratification for determining optimal second and third line therapy for type 2 diabetes: the TriMaster study

Precision medicine aims to treat an individual based on their clinical characteristics. A differential drug response, critical to using these features for therapy selection, has never been examined directly in type 2 diabetes. We tested two hypotheses: 1) individuals with BMI>30kg/m(2), compared...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Med
Main Authors: Shields, Beverley M, Dennis, John M, Angwin, Catherine D, Warren, Fiona, Henley, William E, Farmer, Andrew J, Sattar, Naveed, Holman, Rury R, Jones, Angus G, Pearson, Ewan R, Hattersley, Andrew T
Formato: Artigo
Idioma:Inglês
Publicado: 2023
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7614216/
https://ncbi.nlm.nih.gov/pubmed/36477733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-022-02120-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares